The stock of Netscientific PLC (LON:NSCI) is a huge mover today! The stock increased 4.53% or GBX 2.88 on November 4, hitting GBX 66.38. About 81,330 shares traded hands or 746.92% up from the average. Netscientific PLC (LON:NSCI) has declined 8.16% since April 7, 2016 and is downtrending. It has underperformed by 9.25% the S&P500.
The move comes after 9 months positive chart setup for the GBX 33.24M company. It was reported on Nov, 4 by Barchart.com. We have GBX 107.54 PT which if reached, will make LON:NSCI worth GBX 20.61M more.
More important recent Netscientific PLC (LON:NSCI) news were published by: Businesswire.com which released: “NetScientific plc: Ex Novartis Diagnostics president, Gene Walther is …” on December 14, 2015, also Fool.Co.Uk published article titled: “Is Netscientific PLC A Better Buy Than Smith & Nephew plc And Dechra …”, Businesswire.com published: “NetScientific appoints diagnostics leader Lawrence Cohen as CEO of Glycotest Inc.” on December 16, 2015. More interesting news about Netscientific PLC (LON:NSCI) was released by: Businesswire.com and their article: “NetScientific plc: Wandaâ„¢ Partners with Leading US Hospital Group Dignity …” with publication date: February 29, 2016.
NetScientific plc is a transatlantic healthcare technology company. The company has a market cap of 33.24 million GBP. The Firm develops and manages early/mid-stage healthcare technology companies sourced from strategic partnerships and relationships in the United States and Europe with a primary focus on diagnostics, digital health and therapeutics. It currently has negative earnings. The Firm is engaged in the development of intellectual property.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.